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FOOD FOR THOUGHT 
How many nanoparticles 
can fit on the head of a pin? 
O
ne of the great philosophical 
debates that is said to have 
engaged theologians in the middle 
ages centred on the question: 
‘How many Angels can dance 
on the head of a pin?’ 
Nowadays, this phrase is used to 
characterise pointless, time-wasting 
discussion. So how are we to consider 
technological developments that enable 
the manufacture of food components and 
packaging using particles just a few billionths 
of a metre in diameter? 
The consideration of such particles is a 
very real issue with massive implications for 
us all. What makes the use of nanomaterials 
in food and packaging important is that their 
size gives them very powerful properties. 
Supporters of nanotechnology say that it 
could be used to lengthen the shelf-life of 
food, improve safety and traceability and, 
for example, create packaging that would 
warn if food is going off or approaching its 
‘use by’ date. 
Some believe that by helping to ‘lock’ 
nutrients in food for longer it could make 
a major impact in addressing inadequate 
diets and nutrition in developing countries. 
Opponents counter that the problem of 
poor diets is due to food access and 
poverty, rather than what’s in the food. 
Supporters of nanotechnology suggest 
that it will also allow the creation of healthier 
individual products. For example, nanoparticles 
of chocolate could, in theory, be filled with tiny 
droplets of water to make low-fat chocolate, 
so that people might indulge their taste for 
chocolate without becoming obese. 
For some consumer organisations this raises 
the philosophical question: ‘Why?’ Their view 
is that such scientific progress would add to 
the pressure on children and young people to 
develop a taste for junk foods rather than to eat 
a healthy balanced diet. Others feel it would 
simply be a recognition of the realities of 
people’s lives today. 
Hovering over this debate is the concern 
that some nanoparticles might be able to 
transfer through our gut, harming our health 
and perhaps contributing to chronic diseases. 
The House of Lords’ Select Committee 
on Science and Technology, the previous 
Government and the FSA have all taken the 
view that no food product or packaging using 
nanotechnology should be allowed onto the 
market without proof that it is at least as safe 
as its conventional counterpart. The Agency, 
as a regulator basing its advice and decisions 
on science and evidence, will play a major 
role in this process. 
I hope that in the following pages we have 
begun to tackle the major issues associated 
with nanotechnology that you might be 
interested in. You will find articles outlining 
the basic concerns consumers have with 
nanotechnology, a view from business, 
a summary of the previous Government’s 
position, and descriptions of the research 
already underway to ensure any food 
produced using nanomaterials will be safe. 
Also, in line with the FSA’s commitment 
to be open and transparent, we publish the 
key points raised at a Bite Roundtable on 
Nanotechnology, involving experts from 
industry, science, regulation and, of 
course, consumer organisations. 
If you have any points you’d like to make 
on nanotechnology we’ll try our best to publish 
them. To email or write to me, see the bottom 
of our contents page for contact details. 
But, just in case you were about to launch 
into a discussion on how many nanoparticles 
can fit on the head of a pin, the answer 
(according to the Lords’ select committee), 
is three hundred million nanoparticles, 
each 100 nanometres wide. 
Frank Chalmers 
Editor, Bite 
Supporters of 
nanotechnology 
suggest that 
it will allow 
the creation 
of healthier 
individual 
products.
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IN THE MIX 
Nanotechnology: 
what’s the big
�issue? 
Suncreams, shoe polish, clothing, children’s toys, golf clubs – 
all frequently contain nanoparticles. No one really seems too 
concerned, says Carol Harris. But when it comes to food… 
I
nternational consultancy Cientifica has 
estimated that the nanofoods market 
worldwide was worth $410 milliion in 2006 
and would grow to $5.8 billion in 2012. 
So what’s the big deal? The big deal is 
that nanoparticles have a relatively large surface 
area that enhances their reactivity and functionality;
at the molecular level, they demonstrate very 
different properties to larger quantities of the 
same products. 
This opens up the potential for nanofoods that 
have drastically-reduced levels of fat, salt or sugar 
but that retain all the taste, and coatings and 
packagings that improve food safety during 
processing and in the finished products. 
Another issue generating interest is the 
impact nanofoods could have on ‘healthy eating’. 
In her evidence to the House of Lords’ Select 
Committee on Science and Technology inquiry 
on nanotechnologies and food, Georgia Miller, 
Coordinator of the Friends of the Earth 
Nanotechnology Project, asked: ‘Will the addition 
of nanoadditives to junk foods enable them to be 
marketed for health values, for example increased 
nanoencapsulated omega-3 or iron fortification?’ 
Nanotechnology also presents possible direct 
risks to health. It is possible that the mobility of 
nanomaterials gives them the potential to access 
all areas of the body, including the brain and all 
areas of the cell. 
The lack of open discussion on the implications 
 
of nanotechnology was a key concern of the Lords’ 
committee (see article on page 8). Its primary 
recommendation was for more dialogue and it 
criticised the food industry for a perceived lack of 
transparency about research into the risks, benefits 
and potential of nanotechnology and nanomaterials. 
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Micro-measurements 
The quoted unit of 
measurement, a nanometre 
(nm), is one billionth of a 
metre: a sheet of paper is 
about 100,000nm thick 
Applications 
Products such as suncreams, shoe 
polish, children’s toys and golf clubs 
all frequently contain nanoparticles 
$5.8bn 
The nanofoods 
market is predicted 
to be worth about 
$5.8bn by 2012 
The committee’s report acknowledges 
that in the UK and Europe, work on 
developing nanofoods is still at an early 
stage. But it quotes the FSA’s Chief 
Scientist Dr Andrew Wadge as saying that 
although there is little on the market at 
present, the FSA ‘fully expects that 
to change’. 
If the needs for regulation and protocols 
for testing are pressing, though, one of the 
key difficulties, the FSA told the select 
committee, was that ‘it is not possible to 
provide a definitive list of nanofoods and 
nanoscale food contact materials on the 
EU market, primarily because of the 
absence of an EU-wide register or inventory’. 
The Food and Environment Research 
Agency (Fera) has highlighted the impact 
of ‘regulatory drag’, which is regulations 
inevitably lagging behind the frontiers of 
scientific development. Fera also points to 
risks inherent in testing unique products 
and the difficulties ensuring the tests are 
appropriate (see Fera article on page 24) 
In the US, there is less concern – 
public or scientific – about testing and 
regulation. Even so, there are few 
identified nanofoods on the market. 
The US-based Project on Emerging 
Nanotechnologies (PEN) has, since its 
foundation in 2005, been looking at the 
social, political, and public safety aspects 
of nanotechnology, including nanofoods. 
PEN gave evidence to the House of 
Lords’ select committee, and the 
committee’s report reflects PEN’s call for 
a public database on nanotechnology food 
products, and the need for research to 
understand the behaviour of engineered 
nanomaterials in the gut. 
But in the UK, the food industry appears 
to be wary of joining in open discussion, 
perhaps conscious of the public backlash 
against GM foods in recent years. 
Leatherhead Food Research is one of 
the few organisations entering regularly into 
the debate. Its scientists have contributed 
to conferences and in mass media. In 
2007, it set up the NanoWatch© Working 
Group to investigate nanotechnology in the 
food and drink industry. 
In the US, nanofoods on the market 
include a cooking oil with nanoparticles 
that allegedly block cholesterol from 
entering the bloodstream, and in Europe 
a mayonnaise under development could 
substitute conventional oil droplets for 
water droplets thinly coated with oil, 
reducing the fat but retaining the taste. 
What does it say on the packet? 
Opinion is divided on the implications 
of packaging for food. Nanotechnology 
might increase the complexity of 
packaging materials, which might increase 
waste – or have the opposite effect and 
make it easier to recycle. 
Witnesses to the Lords’ select 
committee talked about food packaging 
with nanomaterials as being the most 
likely application to appear first in the 
mass market, with nanocoatings for food 
preparation surfaces and machinery 
predicted to follow in the next five years. 
An example of this is of chopping boards 
infused with nanosilver because of its 
anti-microbial properties. Nanotechnology 
could also indicate whether food is fresh 
or whether it contains contaminants. 
It could even, in theory, indicate the 
point at which the food is best to eat. 
In this environment, the Internet is 
playing a key role, and anyone can go 
online and order nanoparticles of a 
substance. However, orders for custom-
made nanoparticles are, one producer 
advises, ‘only suitable for our industrial 
customers, since it usually requires (a) a 
minimum of kg-sized quantities ordered, 
(b) thousands of dollars of overhead costs, 
and (c) months of lead time’. 
For some companies, nanotechnology 
is already big business. 
Carol Harris is a freelance writer. 
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HEADINGWHAT’S COOKING? 
Small technologies 
Big business?

Companies that make food 
products, food packaging and 
even food-production machinery 
all stand to benefit from 
developments in nanotechnology. 
But all seem to be saying: 
‘You go first!’ 
Carol Harris 
T
he science is exciting and the potential 
rewards enormous. But for food 
producers and retailers, the cost of 
nanofoods has to be counted in terms 
of consumer attitudes. 
‘We support the use of nanotechnology because 
of its applications in food packaging and food 
safety. The main drivers for innovation are reduction 
of food waste, and cutting down on packaging 
and making it biodegradeable,’ explains Barbara 
Gallani, Director of Food Safety and Science at 
the Food and Drink Federation. ‘There is potential 
in emulsions and nanoencapsulation – if they 
are proven to be safe and cost-effective.’ 
But, she emphasises: ‘We are a long way 
away from products in that area. It is still a big 
technological challenge to deal with the stability 
of nanoemulsions and also to look at the processes 
which would be needed in applications such 
as baking foods at high pressures. The particles 
may not be compatible with the current 
approaches to processing.’ 
Graham Moore of PIRA, which tests packaging 
for industry, agrees that wrapping and coatings are 
We are 
already 
working on 
potential 
systems that 
could lead to 
reduced fat 
metabolism.
’ Professor Vic Morris 
Institute of Food 
Research 
the areas of current interest. ‘There are already a 
number of commercially available products relating 
to use of nanocomposites in films. These can 
significantly improve the barrier characteristics, 
in, for example, moisture and oxygen transmission,’ 
he says. 
As new products, however, ‘the limited growth 
in the market to date is strongly related to cost’, 
he says. ‘Companies are waiting for others to make 
a breakthrough. What needs to be established is 
an analysis of the cost versus benefit for such 
products. Nanocomposite-based films will be more 
expensive on a like-for-like basis with conventional 
films – but their use could mean achieving the 
same functionality but at lower weights. 
‘There have been a number of developments at 
the academic level but what is missing is the link 
with industry.’ 
Kathy Groves of Leatherhead Food Research 
thinks that nanocoatings on food-processing 
machinery could also change food production. 
‘The machines [will] need less cleaning, which 
will involve less downtime. Less cleaning means 
also that the need for cleaning agents such as 
detergents is reduced, and the reduction in build-up 
of deposit on pipes and heat exchangers means a 
more energy efficient process.’ She adds that 
maintenance could also be more efficient: 
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Companies are waiting for others to make a 

breakthrough. What needs to be established 

is an analysis of the cost versus benefit for 

such products.
’ Graham Moore 
PIRA 
coated blades would stay sharper 
for longer. 
Such coatings are not currently used, 
she says, because, ‘the food industry 
needs to know that they will work in their 
particular application and more importantly 
that they are food-safe. It is a very big step 
to replace all the processing equipment 
with nanocoated pipework, and so on, 
and it has to work.’ 
Any business case for nanofoods 
also has to take account of consumer 
attitudes which, if negative, will make 
products uncommercial. Barbara Gallani 
points out that the industry has been 
engaging for years with stakeholder 
forums, the European Safety for Success 
conference, independent networking 
groups and stakeholder engagement 
in the Responsible Nano Forum. 
However, none of the major 
supermarket chains approached by Bite 
felt they had anything to say on 
nanotechnology at the moment. 
Kathy Groves says that some 
information is commercially 
sensitive, but she 
believes the industry 
is also concerned 
about boycotts 
of products. 
‘The consumer 
responses are 
sometimes 
based on lack 
of knowledge – 
on science and on 
how most foods 
are manufactured – 
but also partly on 
misreporting. This 
needs to be addressed 
by a planned education 
proposal.’ 
But work is 
undoubtedly going 
on to develop 
nanofoods. 
Professor 
Vic Morris 
of the 
Institute of Food Research says that 
we could see foods that have improved 
quality and can deliver added health and 
nutritional benefits. ‘We are already 
working on potential systems that could 
lead to reduced fat metabolism and there 
are similar options for reducing glucose 
metabolism and enhanced fermentation 
of carbohydrate in the colon,’ he says. 
‘There are potential applications in 
designing foods to improve possible 
protection against disease. These could 
all potentially lead to foods that could 
contribute to reduced obesity or [that 
have] other health benefits.’ 
Nanoencapsulation is another 
interesting area. ‘There are already food 
products sold via the Internet that claim 
to enhance sweetness and hence reduce 
calories by lowering the total calorific value 
of the food. These are potentially slimming 
products, and nanoencapsulation could 
be used to supplement foods to enhance 
nutritional value [added nutrients],’ 
Professor Morris says. 
Such products could be tested 
within the established procedures and 
regulations, such as those applied by 
the EU to novel foods. More problematic 
are products that could lead to ingestion of 
non-metabolisable materials. ‘Obvious 
examples are accidental release and 
ingestion from food packaging or 
deliberate inclusion in foods.’ 
Some nanomaterials are available on 
the Internet in food supplements with 
claimed health benefits. It is not clear, 
he points out, whether all the health and 
safety claims are tested or regulated. 
Nor, for that matter, is it clear whether 
that worries consumers. 
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HEADINGESSENTIAlS 
Carol Harris In January, the House of Lords’ Select Committee on 
Science and Technology issued a report on its inquiry 
into nanotechnology and foods. Below we pick out 
some key points 
conversation
a little more 


I
ts recommendations cover risk assessment, 
regulation and current research, but the 
House of Lords’ select committee report on 
nanofoods is clear: better communication 
is the overriding priority. 
The select committee views the food industry’s 
reluctance to discuss nanofoods as an 
understandable reaction to the public backlash 
that resulted in the ban on GM foods. But it says: 
‘We consider that this is exactly the type of 
behaviour which may bring about the public 
reaction which it is trying to avert.’ In his evidence 
to the committee, the then Government Science 
Minister Lord Drayson cautioned that there could 
be no effective public engagement ‘if companies 
are not providing clarity about the work that is 
being done and potential applications’. 
One key recommendation of the report is 
therefore the creation by Government of ‘an open 
discussion group, along the lines of the Defra-
sponsored Nanotechnology Stakeholder Forum, 
to discuss issues surrounding the application of 
nanotechnologies in the food sector’. It adds that: 
‘The Government should ensure that concerns of, 
and suggestions made by, the group are published 
and taken into account in policy decision-making 
processes and should report on how these 
concerns are being met at regular intervals.’ 
The report welcomes Government plans for a 
website to tell the public about nanotechnologies 
– with a special emphasis on food – and calls on 
the Government to survey evolving public attitudes 
towards the use of nanotechnologies in the food 
sector as debate progresses. 
However, it is not simply a case of spreading 
the good news. The UK is seen to have a strong 
research base in understanding food nanoscience 
but to lag behind in the application of 
nanotechnologies in this area. 
The committee says the need for more research 
into nanotechnology and food is pressing, given 
the potential for wider benefits to society, for 
example by producing healthier foods or more 
environmentally-friendly packaging. When asked 
whether the Government planned to support such 
research, for example in applying nanotechnology 
to produce lower fat foods to combat obesity, 
Lord Drayson said: ‘This is an area where 
significant research is being undertaken by the 
food companies themselves. The important role 
for research in this area is to address the 
underpinning understanding of the way in which 
the body processes nanomaterials… that should 
be the right focus now for our research, to get a 
handle on that in parallel with the work which is 
taking place within the food companies’. 
Several witnesses to the committee discussed 
the need to develop effective risk assessment of 
nanotechnologies used in food, its packaging and 
processing, and of the testing procedures. 
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The committee singles out the 
key priorities as: 
• characterisation and 
detection of nanomaterials 
• behaviour of 
nanomaterials in the gut 
(including local effects, 
absorption and 
subsequent distribution) 
• effects on the human 
foetus 
It added that certain 
types of medical conditions 
may make people more 
susceptible to the potential risks 
posed by ingested nanomaterials. 
Diseases that cause gastrointestinal 
inflammation, such as inflammatory bowel 
disease or chronic diarrhoea, may allow 
nanomaterials to penetrate the intestinal 
wall more easily. People with inflammatory 
conditions of the lung may be adversely 
affected by nanoparticles. 
Some key recommendations 
of the report 
eir 
ved 
ity.
Ensuring transparency 
The Government [should] work with 
the food industry to secure more 
openness and transparency about th 
research and development and their 
future plans for the application of 
nanotechnologies in the food sector. 
Encouraging testing 
Government should ensure 
research leads to practical tests 
that enforcement authorities can 
use on imported food. 
Publishing information 
The Food Standards Agency creates 
and maintains an accessible list of 
publicly-available food and food 
packaging products containing 
nanomaterials that have been appro 
by the European Food Safety Author 
Regulation and risk assessment 
Risk assessment must underpin testing 
and regulation. But the quoted unit of 
measurement, the nanometre (one 
billionth of a metre), is misleading as a 
means of deciding where the regulations 
come into effect, the committee feels. 
It concludes, rather, that ‘how a substance 
interacts with the body, should be the 
factor that distinguishes a nanomaterial 
from its larger form’. And this will require 
working within the European Union to 
amend legislation to ensure that all 
nanomaterials used in food products, 
additives or supplements fall within 
its scope. 
The Lords’ committee identifies a 
key role for the Food Standards Agency, 
especially as the Agency is sponsoring 
part of an EU project that will investigate 
methods for detecting and measuring 
nanomaterials in food (see Agency 
research, page 12). 
‘We endorse the case-by-case approach 
taken by the European Food Safety 
Authority in assessing the safety of 
The report welcomes
Government plans 
for a website to tell 
the public about 
nanotechnologies.
products,’ and ‘welcome the assurance 
from the Government that the FSA will 
ensure that enforcement authorities are 
made aware of the issues surrounding 
the use of nanomaterials in imported food’. 
Additionally, the report recommends 
that the FSA reviews legislation every three 
years to ensure that regulatory oversight 
and risk assessment keep pace with 
technological development. 
Labelling – no hiding under a blanket 
The committee is clear that ‘blanket 
labelling of nanomaterials on packages 
is not… the right approach to providing 
information about the application of 
nanotechnologies’. 
It recommends that the FSA creates 
and maintains an accessible list of 
publicly-available food and food packaging 
products containing nanomaterials that 
have been approved by the European 
Food Safety Authority. 
Further information 
The House of Lords’ first report on 
Nanotechnology and Foods is 
available online at: 
www.publications.parliament.uk/ 
pa/ld/ldsctech.htm 
 
’ 
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TESTING THE RECIPES 
Carol Harris In late March, the Government launched its strategy  
‘Small Technologies, Great Opportunities’, making clear  
the overriding theme of its response to the House of Lords’ 
report on nanotechnology in food. The strategy allocates  
a number of key roles to the FSA 
key role for the FSA
�
I
n launching the previous Government’s 
strategy on nanotechnology and food, 
Gillian Merron, then Minister of State at 
the Department of Health, emphasised 
in her statement to Parliament the 
potential benefit of nanotechnology to the 
economy and consumers, and stressed the 
importance of public engagement. 
She said: ‘The [Lords’] committee rightly 
highlights the heightened political sensitivities 
about new food technologies and the value  
of effective public communication and 
openness. Therefore, in addition to taking 
forward the other recommendations  
in the report, the Food Standards Agency  
will be working closely with industry, 
consumer groups and other stakeholders  
to ensure that the public have accurate  
and impartial information about the way 
nanotechnologies are being applied to food.’ 
The FSA’s own response to the Lords’ report 
had been discussed earlier in March at the 
FSA’s Board meeting, where the Board 
identified 19 of the Lords’ committee’s 32 
recommendations as having particular 
relevance to its work (see further information). 
Among those of particular importance  
are the Lords’ recommendations 10, 26  
and 32. The first two identify the FSA as  
the organisation to hold information on 
research and development of nanofoods  
and of nanomaterials used in packaging. 
Any such database of research into 
nanofoods will, of necessity, be confidential 
but its aim will be to inform risk assessment 
and help prioritise research. 
The Government says that industry 
participation should be mandatory, as 
voluntary schemes have failed. 
The FSA has made it clear that it will be 
engaging with industry and others to obtain 
information that will inform the development of 
risk assessment and regulations on nanofoods. 
But it has cautioned that a mandatory scheme 
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for reporting research might have the 
effect of diverting research outside the 
scope of such regulation and of 
discouraging its development in the 
UK. It also raised the question of how 
such a scheme might be enforced 
legally. The Agency view is that new 
legislation might be required. 
The FSA told the Government that 
horizon-scanning and information-
gathering are essential and increasing 
its work in this respect is part of the 
current FSA strategy. It added that  
its work programme is looking at 
developing the databases that will 
capture intelligence relating to 
emerging risks. 
Commitment on public 
engagement 
A third key recommendation, number 
32, suggested the establishment of  
an open discussion group, along the 
lines of the Defra-sponsored 
Nanotechnology Stakeholder Forum, 
to discuss issues surrounding the 
application of nanotechnologies in the 
food sector, and the Government has 
asked the FSA to take this forward. 
As an independent body, the FSA 
has a lead role in public engagement 
on nanotechnology and food, it 
believes that this role is as crucial as  
The Government agrees that the FSA 
should formally review and report 
regularly.
its work with the industries involved  
in developing nanotechnology. 
The FSA will also take up the 
committee’s recommendation  
that it create and maintain a list of 
publicly-available food and food-
packaging products that contain 
nanomaterials approved by the 
European Food Safety Authority 
(EFSA). Here the difficulty is one  
of accurate definition rather than of 
assuring compliance. The issue for 
the FSA is the criteria for inclusion  
on the list. The Government suggests 
that in addition to nanomaterials 
evaluated by EFSA, the register could 
make publicly available information  
on materials that may have nanoscale 
elements. The FSA will look at how 
such a register can be set up and 
maintained with others on the new 
discussion group that will look at 
nanotechnology in the food sector. 
Nanotechnologies will also be  
part of the Agency’s programme  
of citizen forums during 2010. There 
is widespread agreement that public 
engagement is essential, as public 
attitudes are critical to the success of 
innovations; such deliberative forums 
provide rich data on attitudes and 
enhance understanding between the 
public, experts and decision-makers. 
The Government is also looking to 
the Agency to ensure that dialogue 
between the food industry and 
individual stakeholders is shared as 
much as possible. The Government 
agreed with the Lords’ report’s main 
recommendation that a lack of 
openness – or even a perception of this 
– would undermine public confidence. 
That said, the Government 
supports the Lords’ committee’s view 
that blanket labelling of all foods and 
packagings that might have included 
nanomaterials is not practical; 
instead, the FSA will take up the  
idea of a permanent consumer-
focused website on nanotechnologies 
that will present information to 
support the register of foods 
containing nanomaterials. 
The Government agreed with the 
views of the Lords’ select committee 
and of the FSA that European 
regulations on novel foods are most 
suitable for amendment to take 
account of emerging technologies  
in food and packagings and coatings 
on the nanoscale. It agrees too with 
the Lords’ view that the FSA should 
formally review and report regularly  
to ensure regulations and risk 
assessments keep pace with 
developing technology. 
This will inform the Government 
approach within the EU, where 
amendments to current legislation  
will be made. The Government  
agrees with the Lords that a formal 
risk-assessment process must be 
developed through EFSA, given the 
uncertainties about the potential  
risks of nanomaterials. 
Further information 
The House of Lords’ Select 
Committee on Science and 
Technology report on 
Nanotechnology and Food is at: 
www.publications.parliament.uk/ 
pa/ld/ldsctech.htm 
The Government response to the 
Lords’ committee report is at:  
www.official-documents.gov.uk/ 
document/cm78/7857/7857.pdf 
The FSA Board paper on 
nanotechnology and food is at: 
food.gov.uk/multimedia/pdfs/ 
board/fsa100306.pdf 
 ’
Bite    Summer 2010    11 
NEW INGREDIENTS 
Manisha Upadhyay 
FSA Novel Foods Unit 
Presented with a new food, one of the FSA’s vital 
roles is to ask: Is it harmful? Manisha Upadhyay, 
from the Food Standards Agency’s Novel Foods 
Unit, outlines some of the FSA-funded research 
underway into nanotechnology and food 
A
lthough tiny, nanoparticles 
have relatively large 
surface areas. This means 
that substances can be 
more reactive at the nano 
level. As a result, nanoparticles have 
unique and largely-unknown 
properties that the Agency needs to 
ensure are safe before they are used 
in food, its production and packaging. 
Toxicology research 
The Agency is taking a lead by 
commissioning two projects that 
will look at toxicokinetics of 
nanomaterials. Toxicokinetics 
is concerned with the ways 
in which a chemical enters 
the human body and 
what happens to it once 
it is there. 
The first project will look at 
nanoparticles in cell models and in 
human volunteers. It will consider the 
effect that different particle size, 
chemistry and surface properties have 
on the absorption of titanium dioxide 
nanoparticles from the gut. The project 
will also look at zinc oxide and silver 
nanoparticles. Nano-zinc and 
nano-silver are already used in the 
food industry in antimicrobial food 
containers and films for wrapping food. 
The second project, 
looking at titanium 
dioxide nanoparticles, 
will complement the 
first project, using a 
different model to 
mimic the action 
of the cells that 
line the small 
intestine. It will 
look at how ingested titanium 
dioxide nanoparticles are absorbed, 
distributed, metabolised and 
excreted in rats. 
The results from these projects 
will increase our understanding of 
the risks posed by nanomaterials and
will help Government regulators and 
scientific committees decide how 
risks from ingesting nanomaterials 
in food, feed and food packaging 
can be assessed. Both projects 
began in February 2010 and are 
due to report in mid-2012. 
The Agency is also jointly funding 
a three-year project on detecting 
engineered nanoparticles (ENPs). 
ENPs are relatively new, so there 
are few established methods for their 
detection and characterisation (see 
Fera article page 24). This project’s 
strategic objectives are to: 
• Provide validated methods for 
analysis and detection of ENPs 
that can be used by food safety 
laboratories including: (1) imaging 
and screening methods that give a 
rapid, reliable result; (2) methods 
for identifying and quantifying ENPs 
from a variety of food matrices 
• Validate methods and proficiency 
testing of laboratories through 
reference materials for selected 
ENP/food matrix combinations 
• Enable exposure and risk assessors, 
official control laboratories and food 
industry quality assurance 
laboratories to assess and monitor 
ENPs in food products 
• Allow dissemination and training in 
the use of new detection methods 
for all relevant stakeholders, 
including Governmental and 
industrial end-users, thereby 
enabling the monitoring of ENPs 
in the EU food chain. 
These projects are in key areas for 
research identified for the Government 
by the Nanotechnology Research 
Strategy Group. 
 
Looking at
�
new properties
�
Further information 
For more on the above 
projects, go to: 
food.gov.uk/gmfoods/novel/nano 
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INTERNATIONAl MENU 
Pooling resources 
across Europe 
Scientists from the European Food Safety Authority 
have for some time been working on risk assessments 
of nanoparticles in food and food packaging, says 
David Gott 
T
he European Food Safety 
Authority (EFSA) established 
a working group on 
nanotechnologies in November 
2007 to look at the actual and 
potential uses of nanotechnologies in food 
and feed, identify associated risks, and 
give guidance on risk-assessment of 
nanotechnologies in food and feed. 
One of the first things the working group 
had to do was exclude from consideration 
what it called ‘natural’ nanoscale 
components that are found in products such 
as mayonnaise or homogenised milk, and 
limit itself to ‘engineered’ nanomaterials. 
It helps to remember that the nanoscale is 
not new and nanoscale components have 
existed in traditionally-produced food for 
a long time – what we can now do is 
deliberately make things in the nanoscale. 
The working group then set about 
assembling all the available data on the fate 
and effects of nanomaterials when they are 
eaten. Based on this we identified data 
gaps, for example the small amount of data 
on oral absorption of nanoparticles and the 
absence of oral toxicity studies. We also 
adapted existing European strategies for 
generic risk-assessment of nanomaterials so 
that they could be applied to food and feed. 
Assessment of nanomaterials 
in Europe 
Separately, two EFSA panels have already 
assessed two nanomaterials – a food 
contact material and a mineral source. 
These provided different challenges. 
The nanomaterial used in the food contact 
material was sandwiched between two 
layers, and the questions were whether it 
migrated out of the material and potentially 
into food, and how sensitive was the 
analytical method used to measure this 
potential migration. For the mineral source, 
the panel was not presented with any data 
to show that there had been any evaluation 
of any risks associated with the substance 
in the proposed nanoform, and so it 
concluded that safety could not 
be established. The European 
Commission subsequently 
excluded this substance from 
a list of approved sources 
in a directive. 
‘Regrouping’ 
To take this work forward 
a new working group has 
been established to 
provide more detailed 
guidance on the data 
requirements for 
assessment of 
nanomaterials used in 
food and feed. This group 
has been asked to produce 
draft guidance by this 
summer. There will be a public 
consultation on this document, 
following which EFSA’s 
Scientific Committee will adopt 
an opinion based on it. 
The scientific working group is 
producing this guidance on the basis 
that further nanomaterials are likely to 
be proposed for use in the future and 
therefore EFSA needs to provide 
manufacturers and consumers with 
a clear vision of what information will 
need to be assessed and why, and how 
confident we will then be in the safety 
of assessed nanomaterials. 
David Gott is a toxicologist in the 
Chemical Risk Assessment Unit at the 
Food Standards Agency, and a member 
of the EFSA Scientific Committee 
working group on nanotechnology and 
the EFSA Panel on Food Additives and 
Nutrient Sources added to Food. 
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ROUND THE TAblE 
Nanofoods: at 
the cutting edge 
Bite asked Charles-Francois Gaudefroy from Unilever, 
Isobel Tomlinson from the Soil Association, Miranda 
Watson from Which?, physicist Professor Richard Jones, 
and Sandy Lawrie from the FSA to sit round a table 
and thrash out some of the key issues surrounding 
nanotechnology. Each prepared an opening statement 
that can found on one of the following pages. 
The roundtable was facilitated by FSA Chief 
Scientist Andrew Wadge 
Andrew: Thanks everyone for being very 
clear about your individual positions. What 
I’ve picked up is a common feeling that 
nanomaterials in food and nanoprocesses 
must not pose any safety concerns in 
terms of human health and that we must 
maintain a level of consumer trust in 
taking this issue forward. 
I’ve identified four areas from your 
opening comments. One is around what 
level of scientific understanding and 
risk-assessment would be sufficient. 
The second is whether the regulatory 
framework is sufficient. The third is about 
providing information to consumers. And 
the final point is what more needs to be 
done in terms of public engagement. 
I’d like to start with what level of 
scientific reassurance and understanding 
is going to be sufficient. 
Isobel: I suppose from our perspective 
there is the worry about chronic long-term 
On the other hand: Charles-Francois Gaudefroy (left) and Miranda Watson (right), listen as Isobel 
Tomlinson and Andrew Wadge discuss the value, or otherwise, of low-fat chocolate 
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The novel foods framework states that before 
you put a product on the market you need to 
get formal pre-market approval.
’Charles-Francois Gaudefroy
Research and Development Director, Unilever
effects, given that scientists have said that 
possibly these particles will accumulate in 
the body, in the cells, and there may be 
chronic long-term effects. So we would be 
concerned that the scientific assessment 
was long-term enough to understand the 
risks over a longer time frame.
Andrew: Do we have enough 
information about the toxicology of 
ingested nanoparticles?
Richard: I think there’s room for more 
data [to be gathered] particularly on 
engineered nanoparticles. And although 
the general assumption is that natural 
nanoparticles are innocuous, this may not 
always be so. A slightly obscure piece of 
science I’ve come across shows that the 
one demonstrated case, to my knowledge, 
where an ingested nanoparticle can lead 
to a protein-folding disease actually 
involved natural nanoparticles formed  
in foie gras.
Andrew: I have to say personally I don’t 
think I’ve consumed enough foie gras to 
be concerned about that particular area.
Charles-Francois: The novel foods 
framework states that before you put a 
product on the market you need to get 
formal pre-market approval and this is only 
given once the regulators, and 
the scientists of the regulators 
– the Food Standard Agency  
or European Food Safety Authority –  
are reassured of their safety.
It’s about proving that there are no 
effects in consuming those products.  
I however support the view that there is  
a scientific challenge going forward and  
that we don’t yet know enough, but this  
will be resolved case by case.
Charles-Francois Gaudefroy,  
Research and Development Director, Unilever
Unilever is a multinational that markets 
food and home and personal care 
products. We’ve built a strong reputation, 
for using novel science and technologies 
to deliver new products or improve 
established ones – and in a  
responsible way.
The decision to apply new technology in 
our products will always be based on a 
comprehensive human and environmental 
safety evaluation, substantiation of 
benefits, regulatory compliance and 
consideration of consumer acceptance.
We believe there is considerable 
potential for benefits through the 
application of specific nanotechnologies 
for healthier food and better home and 
personal care products. The debate 
around human and environmental safety 
and confidence is very important and 
we’re participating in moving it forward. 
We conduct our own research and have 
commissioned research with external 
experts on health and the environment.
We support labelling provisions where 
they provide meaningful specific 
information to consumers. We do not 
support logos that could be seen as risk 
warnings. We believe in codes of 
responsible conduct, ahead of and 
complementary to, any regulation. 
Whereas we do not support a standalone 
regulation of nanotechnologies, we do 
support the evolution, where necessary, 
of the current legislative framework 
based on scientific risk assessment.
We believe that triggers of legislation 
must be based on size as well as on 
characteristic properties of the 
nanoscale. The key element of the 
legislative framework is a definition of 
what constitutes an engineered 
nanomaterial. For us, several factors 
need to be taken into account:
1.  The particle size – the emerging 
international standards propose a 
100-nano threshold.
2.  Deliberate engineering. 
3.  Digestibility for nanomaterials used in 
foods and solubility in conditions of 
use for materials used in home and 
personal care products.
4.  The characteristic properties of the 
nanomaterial compared to the 
non-nano forms. 
Only a comprehensive consideration 
of all these elements will allow 
meaningful and enabling legislation.
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Given that we do not know whether this 
technology is safe, the Soil Association has banned 
manufactured nanoparticles as ingredients und
ts.
’
er 
our organic standards, for food produc
Isobel Tomlinson 
Policy and Campaigns Officer, Soil Association 
Miranda: I would reiterate the need 
to look at things not in isolation, because 
consumers are being exposed 
to nanomaterials in a range of different 
ways… And from an industry perspective 
this is so important because without 
adequate risk-assessment manufacturers 
[might expose] consumers to potentially 
having problems down the line, which 
would seem a real shame because that 
will turn consumers against this technology 
simply because we haven’t done the right 
preparation at the start. 
Sandy: An important part in any risk 
assessment is measurement of exposure. 
And we have had, for example, nano clay 
being proposed for use in plastic bottles. 
The risk assessment from a food safety 
point of view is that this nano clay can’t 
get out of the bottle into the food that might 
be inside the bottle – a beer for example. 
And, therefore, a risk assessment based on 
very strong evidence – a lack of exposure 
to the material – can presumably answer 
your question about long term effects and 
accumulation. Because if the person is not 
exposed to this nanomaterial can there be 
a risk from it? 
Richard: When it comes to packaging 
and the question of particular plastics 
additives, the paradox here is that nano 
is actually not small compared to what 
went before. Typically, nanoparticles are 
bigger and more ‘stuck in’ the plastic 
than the things they may be replacing. 
Isobel: From this discussion, actually 
it does seem to highlight the importance 
of doing a case-by-case assessment of 
nanomaterial. That’s a case for saying 
there does need to be a specific regulation 
and it needs to take each application in 
turn. And where it shows that possibly 
there is a chronic long-term effect then 
that’s looked into. 
Andrew: I’m sensing a level of 
agreement on the case-by-case approach. 
Charles-Francois, you talked about the 
importance of the regulatory framework 
and also the enforcement of that 
regulation. Are you satisfied that it is 
sufficiently strong? 
Charles-Francois: I think the framework 
is sufficiently strong pending some 
adjustment… At the end of the 
day the law says that novel 
food must be authorised pre-market. 
Miranda: [But] we’ve seen problems 
with enforcement in areas outside food, 
where some products that aren’t complying 
with regulation haven’t been picked up by 
Trading Standards. I think we are 
concerned that not enough is being done 
on enforcement. It’s really important that 
the Government’s taking a lead on that. 
Andrew: Sandy, can you tell us who 
would be responsible for enforcing this and 
Isobel Tomlinson, 
Policy and Campaigns Officer, Soil Association 
Following the precautionary principle, 
and given that we do not know at present
whether this technology is safe, the Soil 
Association has banned manufactured 
nanoparticles as ingredients under our 
organic standards, for food and for 
health-and-beauty products. 
We were the first organisation in the 
world to take regulatory action against 
the use of nanoparticles to safeguard 
the public, and this initiative goes to the 
core of the organic movement’s values 
of protecting human health. 
In addition, the Soil Association 
has signed up to a moratorium on 
the commercial release of food, 
food packaging, food contact materials, 
and aggregate chemicals containing 
manufactured nanomaterials until it 
is shown they are safe (through the 
completion of publicly-available peer 
reviewed safety studies) and until 
a nanotechnology-specific regulation 
is introduced. 
The recent House of Lords’ report on 
nanotechnologies in food recognises that 
the current scientific understanding of 
 
how nanoparticles behave in the human 
body is not yet advanced enough to 
predict what kind of impact specific 
nanomaterials might have on human 
health. Persistent nanomaterials are of 
particular concern because they do not 
break down in the stomach and may 
have potential to leave the gut, travel 
through the body and accumulate in 
the cells with long-term effects that 
cannot yet be determined. These 
health impacts are potentially serious. 
Giving evidence to the House of Lords’ 
inquiry, Professor Vyvyan Howard stated 
that he was worried nanoparticles might 
be able to get across the blood-brain 
barrier and this might increase the risk 
of protein misfolding in diseases such 
as Alzheimer’s and Parkinson’s. 
Finally, the Soil Association believes 
that the use of technology in creating 
processed foods with lower fat, salt or 
sugar levels is unnecessary in helping 
people eat more healthily. People can 
improve their diets by eating less 
processed food and more fresh fruit 
and vegetables. 
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Hunger 
Charles-Francois Gaudefroy and 
Isobel Tomlinson differ over whether 
nanotechnology is needed to increase 
agricultural food yields 
how can we be certain that there aren’t lots 
of nanoparticles already out there in food? 
Sandy: The enforcement of any food 
safety regulation is a matter for the local 
authorities. And our job in the Agency is 
to make sure they have the understanding 
and the tools they need to be able to do 
that. We also have quite good relationships 
with food manufacturers and we do 
encourage them to come and speak to 
us when they’re developing products. 
Andrew: So, I see that’s a quite clear 
duty on the FSA to take that forward 
with the rest of Government. 
Isobel: There seems to be a lot of 
uncertainty even when you’re looking for 
nanotechnology and, I could imagine for 
the public, about what nanotechnology is 
out there in food substances. And thinking 
about the role of the FSA – having an official 
mandatory list of the products that contain 
nanotechnology would be a good start. 
Sandy: We have said that we will 
construct a public list of products that 
are on the market that are, or could be 
thought to be, nanoproducts. I think there 
is concern that there might be products 
on the market using nanotechnology that 
industry is not telling us about because it 
seems somehow a negative term. Certainly 
outside of the food area there are products 
where nano has disappeared from the 
marketing, either because the product was 
claiming to use nano and it wasn’t or, more 
likely, because what was initially seen as a 
positive aspect of innovation suddenly 
became looked on with suspicion. 
Charles-Francois: Yes, the word ‘nano’ 
can resonate differently in different places. 
In India or in China or Japan – in Asia 
overall – nano is a positive argument; 
in Europe, much less so. In the US it’s 
more or less like Europe. 
Miranda: The Agency is acknowledging 
the need to gather more intelligence 
about where nanotechnology is being 
used in relation to food. But without 
having a mandatory reporting procedure 
I’m unclear about how you will ever get 
that full intelligence. I’m unclear about 
how a voluntary scheme would deliver 
that intelligence. 
Sandy: There are two aspects to what 
the House of Lords was recommending. 
One was in relation to having a list of 
foods that were on the market, and I think 
that the industry as a whole increasingly 
sees the importance of openness in this 
area, and also the ability to explain to 
consumers where nano is being used, 
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How can we ensure that there’s a level of 
understanding in the Agency and among 
consumers about what you are developing 
and what might be coming in the future?
Richard: I understand why 
people would find it difficult to prise that 
information out from companies. And I 
suppose perhaps one could step back  
a little bit and say actually what we’re 
probably interested in knowing is what 
actually are the broad directions in  
which companies are moving? What do 
they think are the important 
functional elements of the  
new foods that they might want 
to have?
Charles-Francois: 
Unilever’s business is  
about selling to individual 
and where it’s not being used.
The House of Lords also recommended 
a mandatory database in relation to 
products that are not yet on the market. 
This is in relation to products that are 
undergoing research within the food 
industry, and I must say that was a little bit 
surprising. There are powers to find out 
what’s on the market today but not what’s 
going on behind the closed doors  
in the research laboratory.
Andrew: I’m keen to bring in 
Richard and Charles-
Francois because I 
think this is a really 
important point. 
consumers, and we want them to be 
aware of whether our products contain 
nanotechnology or not. Nanotechnology  
is difficult, nanotechnology is expensive, 
so you have to deliver a real benefit to 
actually have a product that is worth it.
Andrew: So where do you see the 
benefits and who do you see benefiting 
from the technology?
Charles-Francois: Protection of the 
food’s quality, i.e. biological, the condition 
of the food through, for example, packaging 
that is enhanced via nano – that’s clearly 
one area where we can see a benefit.  
And that’s a clear direction for research.
Andrew: Miranda, does this answer 
sufficiently your concerns about the 
direction of travel and how we ensure that 
we know what the developments are?
Miranda: To be honest not really. 
I still fail to see how without having a 
mandatory procedure you’re going to  
get the intelligence.
Andrew: Don’t you think there is a 
risk that if there’s a mandatory 
requirement to register products that are 
still at a developmental stage then those 
developments will simply move outside the 
UK and the Agency will, therefore, know 
less about the developments – and that 
Sandy Lawrie: We have to deal with the use of nanomaterials case by case
18    Bite    Summer 2010
 I think we are concerned that not enough 

is being done on enforcement. It’s really 

important that the Government’s taking 

a lead on that.
Miranda Watson 
Head of Social Advocacy, Which? 
wouldn’t be in the interests of consumers? 
Miranda: We’re also pursuing the 
mandatory list at the EU level. In the US 
they’re also looking into it. We need to 
make sure we’re not just looking at it in 
terms of the UK. 
Richard: I think one shouldn’t forget 
that companies like Unilever that have 
a research lab are not the rule in the food 
industry. People will buy ingredients and 
mix them in, and the analogy here is with 
the cosmetics industry. There’s an 
international trade in ingredients. There’s 
some garage somewhere that stuff is mixed
up in. And I think it is going to be difficult 
to capture that research element in the sort
of reporting scheme that’s been proposed. 
Andrew: I think Miranda’s saying that we
need to look at what’s happening 
h the food supply globally. 
And that will not just be, as you say 
Richard, a few large food companies 
making ingredients. 
In the time left I’m particularly interested 
to tease out what I see as a slight 
difference around the table over whether 
producing, for example, a chocolate that 
didn’t make you fat is actually a benefit in 
this day and age. 
Isobel: People should enjoy a small 
amount of chocolate (organic and Fairtrade 
of course!) and eat a diet with lots of fresh 
fruit and vegetables and, I suppose, 
weighing up the negative and positive 
aspects, we might see that the potential 
harmful effects are not worth the risk. 
Andrew: But I can see a lot of people 
being rather attracted towards bars of 
chocolate that don’t make them fat. 
Isobel: Actually, there’s a slight danger 
that these technologies will mean that 
people will eat more processed food. 
Miranda: Clearly, the technology needs 
to be developed with public health priorities 
in mind. But we need to find out what 
consumers want and will find acceptable 
and we’ll have to ask them what they would 
like to see. If technology can be developed 
to make less healthy food healthier, then 
that has to be a good thing so long as it is 
acceptable to consumers. 
Andrew: So how does Unilever know 
what consumers want? Are you going 
to produce a chocolate that doesn’t 
make us fat? 
Charles-Francois: We spend a lot of 
money talking to consumers in focus 
groups doing quantitative and qualitative 
research. And at the end of the day we 
offer a choice, and the easiest 
Miranda Watson, 
Head of Social Advocacy for Which? 
Which? believes that nanotechnologies 
in food have potential to bring 
consumers huge benefits – from safer, 
intelligent packaging to healthier food. 
But a more co-ordinated approach is 
needed to ensure nanotechnologies 
are developed safely and responsibly 
and used to tackle some of the major 
challenges facing the food chain. 
Uncertainties over how this 
technology will affect the body and 
the wider environment are not being 
addressed with enough urgency. It is 
vital that action is taken to improve 
understanding of what’s on the market 
and what is being developed. 
The recent Government strategy 
doesn’t do enough to close gaps in 
 
 
 
the research that will be essential for 
risk-assessment. Nor will it ensure 
effective enforcement to stop 
unapproved products coming on to 
the market. And the failure of the 
Food Standards Agency to support 
a mandatory reporting scheme on 
the use of nano in food means that 
regulators will continue to be in the 
dark on developments. 
Research by Which? shows that 
consumers are interested in 
nanotechnology and its developments, 
including in the food sector, provided 
that they see real benefits, products 
are safe and they can make informed 
choices. But the Government and 
industry need to learn lessons from 
past mistakes – from areas such as 
GM – and involve the public from the 
outset so that products coming on to 
the market are not only accepted but 
also trusted by consumers. 
As a priority, the Government needs 
to take immediate steps to establish a 
mandatory reporting scheme, implement 
a research strategy that ensures the 
safe development of current and 
future applications, create clear 
regulatory guidance and deliver 
effective enforcement. Without these 
urgent steps, we believe there’s a real 
danger that consumer confidence 
will be damaged and that people 
will turn away from the benefits of 
this technology. 
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We’re going to be balancing the positive 
benefits of interventions against potential 
risks. But this assessment will take place in 
the context of people’s instincts about food.
’ Professor Richard Jones 
Professor Richard Jones, 
(in a personal capacity) 
When we talk about nanotechnologies 
in food there are two distinct types of 
issue we need to think about. There are 
the narrow issues, which are whether 
engineered nanoparticles are entering 
the food chain and presenting a danger 
to human health. Then there are broader 
issues arising because we are able to 
alter the nanoscale structure of food 
with much greater control and sense 
of purpose than before. 
We’re going to be balancing the positive 
benefits of interventions against potential 
risks. But it’s important to 
realise that this 
assessment will take 
place in the context of 
people’s instincts 
about their relationship with food. 
The key worry about engineered 
nanoparticles was that a nanoscale 
version of an existing additive – which 
might present new problems of toxicity 
– would slip through a regulatory net. 
But there’s been progress on this 
and, to give one example, you can’t 
buy colloidal silver for human 
consumption in health food shops 
anymore, since it was taken off the 
market following a European Food 
Safety Authority ruling. 
There is the idea of encapsulating 
ingredients and additives to 
protect delicate molecules for 
flavour and aroma and enable 
triggered release of, perhaps, 
nutraceutical molecules and water-
dispersible preparations of fat-soluble 
ingredients. 
But I think the debate on using these 
methods will unfold around the broader 
values behind food. Some people will say 
that if we want food that’s less fattening 
and more nutritious we should just eat 
more fresh fruit and vegetables. Others 
will point to the reality of people’s lives and 
say that if processed food is important in 
people’s diets then manufacturers have 
an obligation to make these products as 
healthy as possible. 
So the toxicity issues are important 
and mustn’t be neglected, but I think 
we need to contextualise them in this 
broader set of values about food. 
decision for our consumers is not to 
pick the product. 
[But] there’s also the issue of the 
protection of nutrients. There are many 
areas in the world, not the UK fortunately, 
not France, where I come from, where 
hunger and nutrition are problems that 
affect the population. In India people are 
not eating enough and they are eating 
badly. If nano can give part of a solution, 
great. To feed the population in 30 years 
the agricultural sector would have to 
double itself by 2050. That’s a challenge 
and if nano can help, great. 
Isobel: Just to counter that very specific 
point – about worrying about doubling 
food yields. These figures assume 
much higher levels of meat and dairy 
consumption in the future but these can 
actually cause ill health, so we would 
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counter those comments about the 
need to double food yields. And 
malnutrition in the developing world is 
generally caused by people not having 
access to healthy food – and that’s an 
issue of poverty. 
Andrew: Let’s move on to the last area 
of our debate. What more should the FSA 
be doing to ensure that there is an 
appropriate level of public 
engagement and debate? 
Miranda: First of all we need 
to drive forward debates with consumers, 
to find out what they want 
out of this technology and would find 
acceptable. The Agency should do this 
now with nanotechnology rather than wait 
until we see the products starting to 
appear en masse on the market. And it 
shouldn’t just be the FSA. Every company 
that’s producing this technology needs to 
be speaking to consumers. 
Isobel: I agree that public engagement 
is the way forward [but] I’m slightly 
Sandy Lawrie, 
Head of Novel Foods Unit, Food Standards Agency 
The FSA’s position on nanotechnology is 
based on our principles of putting the 
consumer first, being open and basing 
our advice on evidence. It’s not our job to 
champion new technologies or promote 
over-precautionary regulation that stifles 
innovation in the food area. But we need 
to be clear that the public is protected 
from potential harm associated with 
new technologies and that people are 
adequately informed about what they’re 
buying and eating. 
In line with these principles we’re 
taking forward a series of actions 
outlined in the Government’s response 
to the Lords’ Science and Technology 
Committee report. 
The term nanotechnology unites a 
range of disparate processes and 
materials solely on the basis that there is 
some element that involves a very small 
size. There is a possibility that changing 
the structure of food or food ingredients 
may affect the properties of the final 
products, particularly their biological 
properties and safety. 
All nanomaterials are not the same, 
and issues such as solubility and 
persistence are important determinants 
of the way that nanomaterials behave. So 
we have to look at them case-by-case. 
Food legislation includes requirements 
for pre-market assessment and 
authorisation of new substances before 
they’re added to food. Our job is to monitor 
the legislation, to make sure it deals 
adequately with substances that may 
be familiar but which in a new nanoform 
may have unexpected properties. Where 
there are gaps in the legislation we’ll press 
for appropriate amendments so that 
nanomaterials are treated essentially 
as separate substances. 
The Agency’s other interests are 
in relation to robust risk-assessment 
and public information about food and 
the understanding of food. The Lords’ 
Science and Technology Committee 
report sets out the actions the FSA will 
be taking, including the sponsoring of 
research and the establishment of a 
register of nanofoods. 
It’s not our job 
to champion new 
technologies or 
promote over-
precautionary 
regulation. But we 
need to be clear that 
the public is protected 
from potential harm.
’ Sandy Lawrie 
Head of Novel Foods Unit, FSA 
concerned that there’s uncertainty about 
what products are out there and about the 
health and safety impact. We need that 
information before explaining to the public 
what these uncertainties are. 
Richard: Public engagement can be 
very constructive. [But] it is important 
to recognise that a lot of this debate isn’t 
actually about whether titanium dioxide 
is toxic, it’s about values. What actually 
do people want from these technologies? 
What are the positives? And I think if one 
frames it better in those terms you’ll get 
a constructive and helpful answer. 
Andrew: I think that the point about 
the values that we all place on food is a 
particularly important one to end on. 
We need to respect these different values. 
We in the Agency also need to ensure 
that there is a very robust safety 
framework to support the assessment of 
any new product and enforcement of it. 
And I think all of us need to continue to 
engage with the public, with a wide range 
of stakeholders, to ensure that there is a 
level of trust. So thanks very much for 
participating. It’s been really helpful. 
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risk assessors
�
Professor Peter 
Gregory 
ACNFP Chair 
It is the job of the Advisory Committee on Novel Foods and 
Processes to advise the authorities in the countries of the 
UK on any matters relating to novel foods and novel food 
processes. Professor Peter Gregory, the committee’s 
Chair, explains how its work relates to nanotechnology 
U
nder EU regulations, any 
business wishing to add an 
ingredient to a food that has 
not been used before, or to 
employ a new process in the 
production or processing of a food, has to 
submit an application to the FSA or its 
counterpart in another EU member state. 
In either case the application will be 
scrutinised by the Advisory Committee on 
Novel Foods and Processes (ACNFP) to 
determine whether the proposed food 
constitutes a risk to the public. 
The committee contains a range of 
expertise including consumer 
representatives, chemists, plant scientists, 
human epidemiologists, social scientists 
and food scientists, and uses the skills of 
its members to come to an assessment 
about actual and potential risks. 
To reach this assessment the committee 
will often ask the applicant for more details 
about aspects of the product or process, 
and sometimes require that additional 
testing is done. For example, in a recent 
application to use an extract of magnolia 
bark in chewing gum, the committee asked 
for more details of the animal testing 
experiments that had been undertaken 
because it was concerned initially about a 
potential adverse effect seen in one of 
the studies. 
The committee insisted that the 
applicant provide additional information to 
enable it to determine whether the effect 
was a cause for concern. Having assessed 
any risks, the committee’s opinion will 
provide the basis for the UK’s position 
on whether the proposed ingredient or 
process can be authorised and on any 
necessary conditions of use. The ACNFP’s 
advice is also passed via the FSA to the 
European Commission for consideration 
by other member states before any 
decision is made on authorisation. 
So, the ACNFP is set up to deal with the 
‘new’ and, because there is normally only 
a limited body of knowledge on which to 
draw, it has to use its skill, judgement and 
ability to look forward in delivering its 
assessments. Because it is dealing with 
novelty, this may also mean that its view 
may change as new evidence becomes 
available. For example, the ACNFP recently 
considered an application that would 
extend the use of an ingredient that it 
previously reviewed and judged to be 
acceptable. When another manufacturer 
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came along with different uses for 
essentially the same product, it had to 
consider whether the combined intake 
would present a risk to consumers. 
Nanotechnology is being researched 
by several major food companies as a 
means of delivering specific nutrients to 
consumers and to improve packaging and 
reduce waste. Nanoparticles already exist 
in some current foods manufactured using 
traditional processes (for example ricotta 
cheese and some chocolate products). 
With more deliberate manipulation of 
ingredients at the nanoscale, other 
nanoparticles may present a risk, 
especially those that are not broken down 
in the stomach or gut and that may enter 
the blood stream and accumulate in cells. 
We do not yet know which types of 
nanoparticles this might apply to nor 
the long-term consequences of such 
accumulation for human health. 
Very few products have appeared 
in the UK, but in the US a number of 
dietary supplements have been marketed 
that claim to contain some sort of ‘nano’ 
component and the expectation is that 
similar products will soon be seeking 
approval for release in Europe. Some 
consumers might be tempted to try these 
new products by purchasing on the 
Internet, but, as with any other food 
product bought from an international 
trader on the Internet, such purchases 
would constitute a ‘personal import’ and 
the normal legal safeguards, including the 
novel foods regulation, may not apply. 
The ACNFP was due to discuss the 
issues surrounding the use of 
nanotechnologies at its public meeting 
in April, but the meeting was postponed 
due to the General Election. The committee 
will also be looking at what is known about 
nanomaterials at an internal ‘forward-look’ 
session that it is also planning for the 
autumn. We are fortunate that Professor 
Stephen Holgate, who provided technical 
advice to the House of Lords’ committee, 
is a member of ACNFP and 
we shall be able to deal in detail with the 
issues that we shall need to consider when 
assessing the risks that such products 
might bring. Early involvement with the 
Some consumers 
might be tempted 
to try these new 
products by 
purchasing on 
the Internet… 
and the normal 
legal safeguards, 
including the novel 
foods regulation, 
may not apply.
’ 
public at our open meeting will also allow us 
to take proper account of concerns of 
consumers and other parties. 
Doing this ahead of any current 
applications from business may also allow 
us to produce some guidelines on the 
sorts of issues that we think any applicant 
will need to consider before making an 
application. It may also highlight the 
priority areas in which we think research 
would be essential if we are to make 
an informed assessment of risk. The 
European Food Safety Authority recently 
set up a working group to develop 
guidance on the potential risks arising 
from applications of nanotechnologies to 
food and the outputs from this will also 
inform our future risk assessments. 
ACNFP’s reputation is high, as 
witnessed by the number of international 
companies that choose to use it as a 
first port of call when entering European 
markets, and we shall deal with the 
opportunities and challenges of this 
new technology with the same robust 
methods of assessment. 
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Measure  
for measure
Dr. Qasim Chaudhry
Principal Research  
Scientist (Fera)
Before you can take measures 
to ensure food containing 
nanoparticles is safe, you have to 
be able to measure what’s in the 
product and what it might do, 
explains Qasim Chaudhry
N
anotechnologies may offer lots of 
benefits to the food sector in terms  
of improved tastes, flavours, textures, 
longer shelf-life, better safety and 
traceability, and healthy food products. 
However, the use of some insoluble and potentially 
biopersistent nanomaterials has raised concerns 
with regard to consumer safety, ethical, policy and 
regulatory aspects.
To address these uncertainties, the Food  
and Environment Research Agency (Fera) has 
established a science base with a focus on  
health and environmental safety of nanomaterials  
in food and related applications.
A major current challenge with regard to ensuring 
the safety of nanotechnology-derived foods is how  
to detect and characterise nanoparticles in complex 
food matrices. This is because food materials 
contain a range of natural structures – some in  
the nanoscale.
A number of methods are currently available  
for characterisation of nanomaterials, such as  
those based on microscopy, spectrometry, light 
scattering, chromatography, size separation, surface 
characterisation, and their different variants and 
combinations. However, these methods need 
validating and streamlining for detection and 
characterisation of nanomaterials in food matrices. 
For example, if used in the current form, different 
methods may yield different measurement results 
for a given sample. It is also essential from a 
regulatory perspective that validated analytical 
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methods are available for any future enforcement 
of nanomaterial limits in food. 
To meet these challenges, Fera is participating 
in an EU project, ‘Nanolyse’, that is aimed at 
developing validated methods for detection and 
characterisation of nanoparticles in food matrices. 
As part of the €4 million project, in which Fera’s 
participation is partly supported by the Food 
Standards Agency, a range of methods will be 
assessed and/or developed for detection and 
characterisation of inorganic and organic 
nanomaterials in food. The three-year project, 
started in January this year, is expected 
to generate very useful methods in due course. 
The analytical measurement (and hence the 
challenge) is also linked to the parameters that 
are, or may be, important in hazard analysis. 
This requires measuring a number of parameters, 
such as weight quantity, number and size range 
of particles, aspect ratio, surface chemistry, 
functionalisation, and so on. And there is extra 
complexity in deciding what to measure, which 
is caused by agglomeration, aggregation and then 
dissociation of engineered nanoparticles (ENPs) 
by digestion. 
Another big challenge with regard to safe and 
sustainable development of nanotechnology 
applications for food is the scarcity of basic 
toxicological data on nanomaterials. In particular, 
there are major knowledge gaps in relation to 
toxicokinetics of nanomaterials, that is, it is not 
known how the orally-ingested nanomaterials will 
behave in the body, and how will they interact with 
biological processes. Fera scientists are carrying 
out research in this area under an FSA-funded 
project ‘Nanotoxicokinetics’. The study will use 
nano- and larger-sized particles of titanium dioxide 
– an approved food additive – for a full kinetic 
study through a series of structured tests to 
generate baseline data that will provide a basis 
for assessment criteria for future developments. 
Fera scientists are also studying silver 
nanoparticles – another nanomaterial that is 
finding increasing use in a variety of consumer 
products – using metabolomics approaches to 
study the interaction of orally-ingested nanoparticles 
with biological systems. 
With FSA support, Fera scientists have also 
recently completed two studies aimed at identifying 
consumer safety and regulatory implications that 
might emerge from nanotechnology applications 
for food ingredients, additives and food contact 
materials. As part of the studies, pioneering 
research was carried out to establish whether any 
FERA
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in an EU project, 
‘Nanolyse’, that is 
aimed at developing 
validated methods 
for detection and 
characterisation 
of nanoparticles in 
food matrices. 
significant amount of nanomaterials incorporated 
in food packaging materials can migrate into food, 
and thus pose a risk to the consumer. Fera has 
also hosted three workshops so far where different 
stakeholders discussed the health and 
environmental safety issues arising from the use 
of nanotechnologies. Another workshop is planned 
for the end of May 2010 to discuss steps towards 
harmonisation of regulatory approaches in relation 
to nanotechnology-enabled food products. 
Other research themes that Fera aims to 
investigate are the fate and behaviour of 
nanomaterials in the environment, their 
ecotoxicological impacts, and the use of lifecycle 
assessment approach to assess the risks of 
nanotechnology-derived consumer products. 
At the EU level, Fera experts are participating 
in the activities of the EC’s Scientific Committee 
on Consumer Safety, and EFSA’s Working Group 
currently developing guidelines for risk assessment 
of nanomaterials in food and feed products. 
Dr. Qasim Chaudhry is a Principal Research 
Scientist at the Food and Environment Research 
Agency of the Department for Environment, 
Food and Rural Affairs. He is a member of the 
European Commission’s Scientific Committee 
on Consumer Safety, and a Visiting Professor 
at the University of Chester. 
Further information 
More on this subject may be obtained from the 

following publications:
�
Chaudhry, Q., Castle, L. and Watkins, 

R. (Editors) Nanotechnologies in Food, 
Royal Society of Chemistry Publishers 
(ISBN 978-0-85404-169-5). 
Chaudhry, Q., Scotter, M., Blackburn, J., 

Ross, B., Boxall, A., Castle, L., Aitken, R. 

and Watkins, R. (2008) Applications and 

implications of nanotechnologies for the food 

sector, Food Additives and Contaminants 25(3): 

241-258.
�
Tiede, K., Boxall, A.B.A., Tear, S.P., Lewis, J., 

David, H. and Hassellov, M. (2008) Detection 

and characterisation of engineered 

nanoparticles in food and the environment, 

Food Additives and Contaminants 

25(7): 795-821.
�
Dr Qasim Chaudhry can be contacted at, email: 
qasim.chaudhry@fera.gsi.gov.uk 
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The Committee on Toxicity of Chemicals in Food, Consumer Products 
and the Environment provides independent scientific advice to the 
FSA and other Government departments and agencies. Committee 
Chair Professor David Coggon looks at its work on nanotechnology 
Ensuring we 
avoid toxic shock 
Professor David Coggon 
Chair, Committee on Toxicity 
E
very ye
Chemi
and th
sister c
carcin
scanning activitie
rapid growth in n
risk assessment 
priority. We agree
ar, the Committee on Toxicity of 
cals in Food, Consumer Products 
e Environment, along with our 
ommittees on mutagenicity and 
ogenicity, undertakes horizon 
s. In 2004 we recognised the 
anotechnology and identified the 
of nanomaterials as an emerging 
d that we should undertake a 
review and produce a baseline statement on what 
was then known about the toxicology of 
nanomaterials. During that year we also discussed 
the Royal Society and the Royal Academy of 
Engineering report ‘Nanoscience and 
nanotechnologies: opportunities and uncertainties.’ 
We took the view that a single joint statement 
from all three committees would be the best 
approach, and we published our findings in 2005. 
We excluded from our initial review nanomaterials 
that would be considered under regulatory risk 
assessment schemes, such as those designed for 
use in human medicines or medical devices. 
Much of the available information at that time 
came from work on particle toxicity and air pollution. 
Few nanomaterials had been tested toxicologically, 
and only very limited toxicological data were 
available. However, we expected a substantial 
increase in the number of nanomaterials that would 
be produced industrially, and in the range of their 
commercial applications. Our challenge was to 
decide whether we could perform a risk assessment 
for nanomaterials and, if so, how. 
We decided that a definition of nanomaterials as 
having one dimension less than 100 nanometres 
was too rigid, and that a pragmatic case-by-case 
approach based on physicochemical properties as 
well as size was appropriate. We considered that 
there was no need to develop a new approach to risk 
assessment for nanomaterials. We recognised the 
importance of particle size, surface area and surface 
chemistry as determinants of nanomaterial toxicity. 
However, provided studies were designed with 
these properties in mind, and incorporated 
endpoints sufficiently sensitive to identify effects 
predictive of potential adverse outcomes in humans, 
current hazard identification tests would be suitable. 
For example, it might be appropriate to support 
in vitro mutagenicity tests with imaging data on 
particle sizes. We suggested a systematic tiered 
approach to the toxicological investigation of 
nanomaterials, with studies initially focused on 
cell types receiving the highest nanoparticle dose 
identified in biodistribution studies, followed by 
in vivo studies using appropriate routes of exposure. 
During our discussions we realised that 
information on medical applications of nanoparticles 
might provide relevant information on structure-
activity. Our secretariat therefore subsequently 
liaised with the Medicines and Healthcare products 
Regulatory Agency (MHRA), which in 2007 
produced a review of information on the toxicology 
of nanoparticles used in healthcare. 
This review, which explored whether healthcare 
nanoparticles presented any new toxic hazards, 
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was based on published literature from 
the previous five years supplemented by 
additional product-specific information. 
It did not identify any unique mechanisms 
of toxicity for healthcare nanoparticles, 
and we thus remained of the view that 
conventional toxicological assessment 
should be sufficient to identify toxic 
hazards from biodegradable healthcare 
nanoparticles. Nevertheless, it was 
important to ensure study designs were 
appropriate to the nanoparticle under 
investigation. While the standard 
toxicological test batteries would detect 
potential adverse effects of healthcare 
nanoparticles, there was insufficient 
information to exclude the possibility of 
effects not detectable by these methods. 
In responding to the MHRA review, 
we also took the opportunity to clarify 
the purpose of the initial, wide-ranging 
in vitro investigations suggested in our 
nanotoxicology testing strategy. The role 
of in vitro testing was intended as part of 
a tiered approach to decision-making and 
not a means of detecting toxicity endpoints 
other than genotoxic hazards. Data on 
bioavailability and biodistribution were 
critical in risk assessment for nanoparticles, 
and such information could not be obtained 
from in vitro studies. Having considered the 
findings on healthcare nanoparticles, we 
acknowledged there were only limited data 
on extrapolation from animals to humans, 
and that further consideration of appropriate 
uncertainty factors would be required once 
data emerged. 
We concluded that the approach to 

the risk assessment of biodegradable and 

non-biodegradable nanoparticles should 

be different, since the available evidence 
indicated that non-biodegradable 
nanoparticles could cause cell death 
through their physical interaction with cells. 
In contrast, biodegradable nanoparticles 
were less likely to have toxicity intrinsic to 
their nanoparticulate form. 
The information reviewed indicated that 
formulation, that is the matrix in which the 
nanomaterial is present, can affect surface 
charge and particle size and influence 
the resulting toxicity. This suggested that 
product-specific assessments of 
nanoparticles were needed, with clear 
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…six years on we are proud not only to 
have articulated one of the first strategies 
for the risk assessment of nanoparticles, but 
also that this approach has been reflected 
in subsequent international strategies.
descriptions of the formulations tested. 
We suggested that effects of formulation on 
toxicity should be reconsidered in the future. 
For pharmaceuticals, incorporation into 
nanoparticle formulations can greatly 
influence the biodistribution (and hence 
toxicity) of included chemicals. Indeed the 
intention behind many such formulations 
is to facilitate drug delivery across tissue 
barriers. There was little evidence that 
the biodistribution of other chemicals 
not physically included in the original 
formulations, but accidentally present 
in the body at the same time as the 
nanoparticles, can be so influenced. 
However there was at least a theoretical 
possibility that freshly generated 
nanoparticles with reactive surfaces 
could significantly bind and alter the 
biodistribution of other xenobiotics. Such 
effects would not represent nanoparticle 
toxicity per se, but would represent a 
consequence of co-exposure. 
In 2008 we were asked to comment on 
a draft opinion on nanotechnology in food 
and feed that had been compiled by the 
Scientific Committee of the European Food 
Safety Authority (EFSA). The risk assessment 
strategy in the opinion was similar both to the 
strategy outlined in our own earlier joint 
statement, and also that in an opinion of the 
EU Scientific Committee on Emerging and 
Newly Identified Health Risks. 
The EFSA opinion provided a very good 
summary of available information. There 
was a lack of data on biological effects of 
nanoparticles following oral exposure. One 
characteristic of nanoparticles was that 
their surface characteristics were mutable 
and could be markedly altered by relatively 
small changes in formulation. This ability to 
change physical characteristics was a 
scientific and a regulatory challenge. As 
we had noted from the review of
healthcare products, one implication was 
a possible need for increased testing of 
products rather than ingredients. 
The EFSA opinion also drew out more 
clearly the issues around dose metrics (for 
example weight or surface area), but was 
unable to provide guidance on which dose 
metrics should be used. Together with the 
Advisory Committee on Novel Foods and 
Processes, we were disappointed that 
there were still so few toxicological data 
available on nanoparticles three years 
after our first statement. 
So, six years on we are proud not 
only to have articulated one of the first 
strategies for the risk assessment of 
nanoparticles, but also that this approach 
has been reflected in subsequent 
international strategies. At the same time, 
we are disappointed that there has been 
such slow progress in building the 
database on the toxic effects of 
nanomaterials, and thereby reducing the 
uncertainties in risk assessment. 
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Inveterate 

inventor
�
C
harles-Francois Gaudefroy has 

been with Unilever for nearly 

20 years. After different 

assignments in product and 

packaging development, he 

was appointed R&D Director for Unilever 

Home and Personal Care, UK, and held 

that post from 2003 to 2007. ‘These were 

four very happy years and an amazing 

experience,’ he says. Since 2007, as 

Regulatory Affairs Director, his job has 

been to understand the impact of 

emerging regulations, interact with 

stakeholders and ensure compliance 

by the company. He is married with 

three daughters. 

Q.How did your career bring you to 
your present job? 

A.By accident, or by luck. I was the UK R&D Director for Unilever at the time 

of significant regulatory activity in the field 

of chemicals and increasingly had to 

engage with other stakeholders. I was then 

asked to lead the implementation of the 

new regulatory framework and engage with 
other partners on emerging discussions, 

such as nanotechnologies.
�
Q.What’s the worst job you’ve ever 
had and why?
�
A.Oddly enough, I have enjoyed every 
job, as they were all very different. 

The worst job would be to wake up and 

think: ‘Here we go again.’
�
Q.What would you really want to do 
if you weren’t in your current job?
�
A.I would love to retire for a few years 
(I have a family and interests in 

food, music and new technologies) and 

then, at a later stage, go back to product 

development. I like the idea of developing 

ideas that make life easier. 

Q.Is it true that you are an inventor? Have you invented anything 
we’d recognise? 
A.As an R&D professional that is what you are paid for. My name is on a 
couple of designs of bottles of hair 
products and on a patent relating to a 
dishwashing machine cleaner. 
Q.Are there differences in the French and British attitudes towards 
nanotechnology and food? 
A. On nanotechnologies, I think the attitudes have more similarities than 
differences. People want the benefits of 
the products and no risk, and they want to 
have the choice. Businesses and 
regulators, like people, want to ensure food 
remains safe and affordable. 
Q.You travelled here by train [from France]. How big is your carbon 
footprint? 
A. I essentially like the experience of travelling by train as opposed to 
going via airports. I believe in everybody 
taking small actions that eventually make a 
big difference, added to major technology 
changes. I try to work with my computer 
and my phone rather than travelling (but I 
am always keen to come back to London). 
Q.Do you have a secret passion? 
A. I love food, and I like to go to a restaurant and then try to replicate 
the recipe. 
Q. If you were shipwrecked on a desert island and could rescue only 
one piece of music what would it be? 
A.I equally love Depeche Mode’s singles, the Miserere from Allegri and 
the Portrait of a Romantic by John Surman. 




Name: Charles-Francois 
Gaudefroy 
Current position: 
Research and 
Development Director, 
Regulatory Affairs, 
Consumer Confidence 
and Sustainability, 
Unilever 
Previous position: 
R&D Director, Home 
and Personal Care, 
Unilever UK 
Driven by: 
First learning, then 
exploring different 
options and developing 
new ideas 
I like the idea 
of developing 
ideas that 
make life 
easier.
’ Charles-Francois 
Gaudefroy 
R&D Director, Unilever 
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Adopting a sustainable 
approach to life 
I
sobel Tomlinson has been Policy 
and Campaigns Officer for the Soil 
Association, a charity campaigning for 
planet-friendly food and farming, since
November 2009. She is responsible 
for researching a wide range of topics – 
from nanotechnology and animal welfare 
to low carbon food and farming. She also 
attends stakeholder meetings and gives 
talks about the Soil Association’s work. 
Before joining the Soil Association she was 
a teaching fellow in the geography 
department at Keele University and did 
post-doctoral research on plant and tree 
diseases at Imperial College. 
Q.How did your career bring you to where you are? 
A.I have a BSc in environmental policy and management and my Ph.D 
examined the evolution of organic food 
and farming policy in the UK from 1980 to 
the present day. I wanted to be part of a 
movement trying to make our food system 
and diets healthier and more sustainable. 
Luckily for me, the Soil Association was 
looking for someone to do the research for 
their policy and campaigns team at just the
right time. 
Q.What’s the worst job you’ve ever had and why? 
A.I worked in a well-known fast-food sandwich bar for three-and-a-half 
days. As a vegetarian, unpacking and 
weighing the meat fillings was just 
too much. 
Q.What have been your most difficult life-changes in achieving 
a sustainable lifestyle? 
A.Achieving a sustainable lifestyle isn’t difficult, it’s fun! Although, it is 
Name: Isobel Tomlinson 
Current position: Policy and 
Campaigns Officer, Soil Association 
Previous position: Post-doctoral 
Researcher, Imperial College London 
Driven by: Helping to make our 
food system and diets healthier 
and more sustainable 
I wanted to be part 
of a movement trying 
to make our food 
system and diets 
healthier and more 
sustainable.
’ Isobel Tomlinson 
Policy and Campaigns Officer, 
Soil Association 
sometimes difficult getting your friends 

and family to see it like that – especially 

when you say you don’t want to fly on 

holiday! But I think I have won my family 

around now – we had a super trip to 

Prague by train.
�
Q.If you could introduce one new 
law what would it be? 

A.Over 600,000 children in England 
and Wales go to nursery for up to 10 

hours a day. The Soil Association wants 

better regulation for the food served to 

children in all early-years settings and better 

inspection to make sure nurseries stick 

to these rules. We are also asking for 

better training in early-years nutrition for 

nursery care and catering staff and for 

one Government department to be 

accountable for nursery food.
�
Q.What is your favourite 
food?
�
A.Dark chocolate – organic and 
Fairtrade of course!
�
Q.What’s your carbon 
footprint like?
�
A. I think it is probably not too bad. 
I’ve given up flying and don’t have 

a car, but I still travel around a lot by train. 

I am vegetarian and I try to eat local and 

organic food whenever I can. I would 

love to have solar panels or a wind 

turbine on my flat, but that’s not 

possible at the moment.
�
Q.If you were shipwrecked on a desert island and could rescue 
only one book, what would it be? 
A.‘Reading Lolita in Tehran: A Memoir in Books’, by the Iranian author 
Azar Nafisi. 
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Nanotechnology Glossary
�
Who’s who 
ACNFP – Advisory Committee on Novel Foods and Processes.
�
The Board – The Board of the Food Standards Agency.
�
COT – Committee on Toxicity of Chemicals in Food, 

Consumer Products and the Environment.
�
COM – Committee on Mutagenicity in Food, Consumer 

Products and the Environment.
�
COC – Committee on Carcinogenicity in Food, Consumer 

Products and the Environment.
�
Defra – Department for the Environment, Food and 

Rural Affairs.
�
EC – European Commission.
�
EFSA – European Food Safety Authority.
�
ENP Engineered nanoparticles.
�
EU – European Union.
�
FDF – Food and Drink Federation.
�
Fera – Food and Environment Research Agency.
�
FSA – Food Standards Agency.
�
GM – Genetically modified.
�
MHRA – Medicines and Healthcare products 

Regulatory Agency.
�
NRCG – Nanotechnology Research Coordination Group 

(superseded in January 2010 by the Nanotechnology 

Research Strategy Group).
�
NanoLyse – A research project that focuses on the 

development of validated methods for the analysis 

of engineered nano-particles in food and beverages.
�
NSF – Nanotechnology Stakeholder Forum.
�
PEN – Project on Emerging Nanotechnologies (US-based).
�
PIRA – An organisation that does testing and technical 

evaluation of products for the packaging, paper and 

printing industries.
�
What’s what 
Agglomeration – The creation of larger particles by a 
number of smaller ones by mutual attraction via chemical 
forces; this happens more easily for nanosized particles 
than for larger ones. 
Barrier property – The ability of packaging materials to 
prevent the passage of gas, liquids and other permeable 
substances. 
Biodegradable – Able to be broken down within the 
body or in the environment. 
Biodistribution – The locations of a substance within 
the body. 
Biopersistent – Not biodegradable. 
Bioscience – Any science dealing with the structure 

and behaviour of living organisms.
�
Biotechnology – Any technological application of biological 

organisms or substances for a specific use.
�
Emulsion – A mixture of two liquids that do not mix, where 

one is dispersed in the other in the form of fine droplets.
�
Gastro-intestinal tract – The digestive system or ‘gut’.
�
Genotoxic – The ability of a substance to cause DNA 

damage.
�
Insoluble material – A substance that cannot be dissolved.
�
In vitro testing – Studies using biological material outside 

the living animal (literally in glass).
�
In vivo studies – Studies using living organisms, for 

example animal testing.
�
Matrix (ie food matrix) – The medium in which a substance 

or object is embedded.
�
Mutable – Able to be changed.
�
Mutagenicity – The ability to cause a change in DNA, 

resulting in a change in the characteristics of a living 

organisms or a single cell. 

Nanoencapsulation – The coating or enclosing of a 

substance, as if within a capsule, within another material 

at the nanoscale level.
�
Nanofoods – Foods produced using nanotechnology, 

or containing nanoscale ingredients.
�
Nanometrology – The science of measurement at the 

nanoscale level.
�
Nanoparticles – Particles that can be measured at the 

nanoscale.
�
Nanoscale – Usually taken to refer to objects in the range 

of 1 to 100 nanometres. One nanometre (nm) is a billionth 

of a metre.
�
Nanotechnology – The ability to understand and 

manipulate materials at the nanoscale.
�
Nanotoxicology – The study of the nature, effects and 

detection of harmful nanoscale substances on living 

organisms.
�
Toxicodynamics – The process of interaction of chemical 

substances with target sites and the subsequent reactions 

leading to adverse effects.
�
Toxicokinetics – The study of the fate of chemical 

substances in the body, including a mathematical 

account of their absorption, distribution, metabolism 

and excretion.
�
Toxin – A poisonous substance produced by living cells 

or organisms.
�
Xenobiotics – Substances that do not occur naturally 

in the body.
�
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